HEADER APOPTOSIS/INHIBITOR 07-FEB-14 4OQ5
TITLE CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-(4-
TITLE 2 METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL)SULFONYL]AMINO}BENZOIC
TITLE 3 ACID
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-
COMPND 3 1;
COMPND 4 CHAIN: A, B, C, D, E, F;
COMPND 5 FRAGMENT: UNP RESIDUES 174-326;
COMPND 6 SYNONYM: BCL-2-LIKE PROTEIN 3, BCL2-L-3, BCL-2-RELATED PROTEIN
COMPND 7 EAT/MCL1, MCL1/EAT;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MCL1, BCL2L3;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS APOPTOSIS-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.M.PETROS,S.L.SWANN,D.SONG,K.SWINGER,C.PARK,H.ZHANG,M.D.WENDT,
AUTHOR 2 A.R.KUNZER,A.J.SOUERS,C.SUN
REVDAT 2 28-FEB-24 4OQ5 1 REMARK SEQADV
REVDAT 1 12-MAR-14 4OQ5 0
JRNL AUTH A.M.PETROS,S.L.SWANN,D.SONG,K.SWINGER,C.PARK,H.ZHANG,
JRNL AUTH 2 M.D.WENDT,A.R.KUNZER,A.J.SOUERS,C.SUN
JRNL TITL FRAGMENT-BASED DISCOVERY OF POTENT INHIBITORS OF THE
JRNL TITL 2 ANTI-APOPTOTIC MCL-1 PROTEIN.
JRNL REF BIOORG.MED.CHEM.LETT. V. 24 1484 2014
JRNL REFN ISSN 0960-894X
JRNL PMID 24582986
JRNL DOI 10.1016/J.BMCL.2014.02.010
REMARK 2
REMARK 2 RESOLUTION. 2.86 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.4
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.15
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2
REMARK 3 NUMBER OF REFLECTIONS : 26737
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.200
REMARK 3 R VALUE (WORKING SET) : 0.198
REMARK 3 FREE R VALUE : 0.239
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010
REMARK 3 FREE R VALUE TEST SET COUNT : 1340
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 13
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.98
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.21
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2601
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2187
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2478
REMARK 3 BIN R VALUE (WORKING SET) : 0.2170
REMARK 3 BIN FREE R VALUE : 0.2536
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.73
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 123
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 7240
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 222
REMARK 3 SOLVENT ATOMS : 154
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 73.89
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.49
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -5.63980
REMARK 3 B22 (A**2) : 2.98960
REMARK 3 B33 (A**2) : 2.65010
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 1.31050
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.348
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.354
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 7728 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 10480 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 2768 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 180 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 1264 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 7728 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 946 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 9646 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.17
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.27
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.12
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4OQ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-14.
REMARK 100 THE DEPOSITION ID IS D_1000084810.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26737
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.855
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.86
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.20
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M MES, 30%
REMARK 280 W/V PEG5000 MME, PH 6.5, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.87500
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 4
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 5
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 6
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: F
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 164
REMARK 465 THR A 165
REMARK 465 LEU A 166
REMARK 465 VAL A 167
REMARK 465 PRO A 168
REMARK 465 ARG A 169
REMARK 465 GLY A 170
REMARK 465 SER A 171
REMARK 465 ILE A 264
REMARK 465 ASP A 323
REMARK 465 LEU A 324
REMARK 465 GLU A 325
REMARK 465 GLY A 326
REMARK 465 GLY B 164
REMARK 465 THR B 165
REMARK 465 LEU B 166
REMARK 465 VAL B 167
REMARK 465 PRO B 168
REMARK 465 ARG B 169
REMARK 465 GLY B 170
REMARK 465 SER B 171
REMARK 465 ASP B 323
REMARK 465 LEU B 324
REMARK 465 GLU B 325
REMARK 465 GLY B 326
REMARK 465 GLY C 164
REMARK 465 THR C 165
REMARK 465 LEU C 166
REMARK 465 VAL C 167
REMARK 465 PRO C 168
REMARK 465 ARG C 169
REMARK 465 GLY C 170
REMARK 465 SER C 171
REMARK 465 VAL C 321
REMARK 465 GLU C 322
REMARK 465 ASP C 323
REMARK 465 LEU C 324
REMARK 465 GLU C 325
REMARK 465 GLY C 326
REMARK 465 GLY D 164
REMARK 465 THR D 165
REMARK 465 LEU D 166
REMARK 465 VAL D 167
REMARK 465 PRO D 168
REMARK 465 ARG D 169
REMARK 465 GLY D 170
REMARK 465 SER D 171
REMARK 465 VAL D 321
REMARK 465 GLU D 322
REMARK 465 ASP D 323
REMARK 465 LEU D 324
REMARK 465 GLU D 325
REMARK 465 GLY D 326
REMARK 465 GLY E 164
REMARK 465 THR E 165
REMARK 465 LEU E 166
REMARK 465 VAL E 167
REMARK 465 PRO E 168
REMARK 465 ARG E 169
REMARK 465 GLY E 170
REMARK 465 SER E 171
REMARK 465 ASP E 323
REMARK 465 LEU E 324
REMARK 465 GLU E 325
REMARK 465 GLY E 326
REMARK 465 GLY F 164
REMARK 465 THR F 165
REMARK 465 LEU F 166
REMARK 465 VAL F 167
REMARK 465 PRO F 168
REMARK 465 ARG F 169
REMARK 465 GLY F 170
REMARK 465 SER F 171
REMARK 465 VAL F 321
REMARK 465 GLU F 322
REMARK 465 ASP F 323
REMARK 465 LEU F 324
REMARK 465 GLU F 325
REMARK 465 GLY F 326
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 197 -92.34 -145.15
REMARK 500 ARG A 201 86.85 55.39
REMARK 500 SER A 255 -124.23 -83.91
REMARK 500 ASP A 256 -57.40 59.47
REMARK 500 VAL A 321 -105.76 -106.46
REMARK 500 LYS B 197 -92.23 -144.98
REMARK 500 ARG B 201 86.75 55.31
REMARK 500 SER B 255 -125.33 -84.99
REMARK 500 ASP B 256 -62.40 60.53
REMARK 500 VAL B 321 -93.49 -121.20
REMARK 500 LYS C 197 -92.75 -145.23
REMARK 500 SER C 202 70.04 53.40
REMARK 500 ASP C 256 107.47 71.73
REMARK 500 LYS D 197 -92.95 -145.38
REMARK 500 ARG D 201 -132.59 77.97
REMARK 500 SER D 255 -127.23 -84.95
REMARK 500 ASP D 256 -60.29 58.56
REMARK 500 LYS E 197 -93.68 -145.83
REMARK 500 ARG E 201 85.05 55.42
REMARK 500 SER E 202 70.10 53.96
REMARK 500 SER E 255 -123.18 -84.89
REMARK 500 ASP E 256 96.24 29.19
REMARK 500 PHE E 319 62.00 -105.71
REMARK 500 VAL E 321 -124.44 -95.83
REMARK 500 LYS F 197 -92.59 -145.36
REMARK 500 ARG F 201 85.93 54.81
REMARK 500 SER F 202 70.35 53.25
REMARK 500 SER F 255 -124.91 -84.70
REMARK 500 ASP F 256 97.67 24.80
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU B 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU C 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU D 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU E 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU F 401
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4OQ6 RELATED DB: PDB
REMARK 900 HUMAN MCL-1 BOUND TO INHIBITOR 36
DBREF 4OQ5 A 174 326 UNP Q07820 MCL1_HUMAN 174 326
DBREF 4OQ5 B 174 326 UNP Q07820 MCL1_HUMAN 174 326
DBREF 4OQ5 C 174 326 UNP Q07820 MCL1_HUMAN 174 326
DBREF 4OQ5 D 174 326 UNP Q07820 MCL1_HUMAN 174 326
DBREF 4OQ5 E 174 326 UNP Q07820 MCL1_HUMAN 174 326
DBREF 4OQ5 F 174 326 UNP Q07820 MCL1_HUMAN 174 326
SEQADV 4OQ5 GLY A 164 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 THR A 165 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 LEU A 166 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 VAL A 167 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 PRO A 168 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ARG A 169 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY A 170 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 SER A 171 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 MET A 172 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ASP A 173 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY B 164 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 THR B 165 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 LEU B 166 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 VAL B 167 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 PRO B 168 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ARG B 169 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY B 170 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 SER B 171 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 MET B 172 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ASP B 173 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY C 164 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 THR C 165 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 LEU C 166 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 VAL C 167 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 PRO C 168 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ARG C 169 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY C 170 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 SER C 171 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 MET C 172 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ASP C 173 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY D 164 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 THR D 165 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 LEU D 166 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 VAL D 167 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 PRO D 168 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ARG D 169 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY D 170 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 SER D 171 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 MET D 172 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ASP D 173 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY E 164 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 THR E 165 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 LEU E 166 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 VAL E 167 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 PRO E 168 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ARG E 169 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY E 170 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 SER E 171 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 MET E 172 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ASP E 173 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY F 164 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 THR F 165 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 LEU F 166 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 VAL F 167 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 PRO F 168 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ARG F 169 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 GLY F 170 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 SER F 171 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 MET F 172 UNP Q07820 EXPRESSION TAG
SEQADV 4OQ5 ASP F 173 UNP Q07820 EXPRESSION TAG
SEQRES 1 A 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG
SEQRES 2 A 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN
SEQRES 3 A 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER
SEQRES 4 A 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG
SEQRES 5 A 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE
SEQRES 6 A 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP
SEQRES 7 A 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE
SEQRES 8 A 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU
SEQRES 9 A 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR
SEQRES 10 A 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER
SEQRES 11 A 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU
SEQRES 12 A 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE
SEQRES 13 A 163 HIS VAL GLU ASP LEU GLU GLY
SEQRES 1 B 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG
SEQRES 2 B 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN
SEQRES 3 B 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER
SEQRES 4 B 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG
SEQRES 5 B 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE
SEQRES 6 B 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP
SEQRES 7 B 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE
SEQRES 8 B 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU
SEQRES 9 B 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR
SEQRES 10 B 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER
SEQRES 11 B 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU
SEQRES 12 B 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE
SEQRES 13 B 163 HIS VAL GLU ASP LEU GLU GLY
SEQRES 1 C 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG
SEQRES 2 C 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN
SEQRES 3 C 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER
SEQRES 4 C 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG
SEQRES 5 C 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE
SEQRES 6 C 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP
SEQRES 7 C 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE
SEQRES 8 C 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU
SEQRES 9 C 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR
SEQRES 10 C 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER
SEQRES 11 C 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU
SEQRES 12 C 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE
SEQRES 13 C 163 HIS VAL GLU ASP LEU GLU GLY
SEQRES 1 D 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG
SEQRES 2 D 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN
SEQRES 3 D 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER
SEQRES 4 D 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG
SEQRES 5 D 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE
SEQRES 6 D 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP
SEQRES 7 D 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE
SEQRES 8 D 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU
SEQRES 9 D 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR
SEQRES 10 D 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER
SEQRES 11 D 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU
SEQRES 12 D 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE
SEQRES 13 D 163 HIS VAL GLU ASP LEU GLU GLY
SEQRES 1 E 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG
SEQRES 2 E 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN
SEQRES 3 E 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER
SEQRES 4 E 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG
SEQRES 5 E 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE
SEQRES 6 E 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP
SEQRES 7 E 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE
SEQRES 8 E 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU
SEQRES 9 E 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR
SEQRES 10 E 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER
SEQRES 11 E 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU
SEQRES 12 E 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE
SEQRES 13 E 163 HIS VAL GLU ASP LEU GLU GLY
SEQRES 1 F 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG
SEQRES 2 F 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN
SEQRES 3 F 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER
SEQRES 4 F 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG
SEQRES 5 F 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE
SEQRES 6 F 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP
SEQRES 7 F 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE
SEQRES 8 F 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU
SEQRES 9 F 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR
SEQRES 10 F 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER
SEQRES 11 F 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU
SEQRES 12 F 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE
SEQRES 13 F 163 HIS VAL GLU ASP LEU GLU GLY
HET 2UU A 401 57
HET 2UU B 401 57
HET 2UU C 401 57
HET 2UU D 401 57
HET 2UU E 401 57
HET 2UU F 401 57
HETNAM 2UU 4-(4-METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL)
HETNAM 2 2UU SULFONYL]AMINO}BENZOIC ACID
FORMUL 7 2UU 6(C30 H23 N O5 S)
FORMUL 13 HOH *154(H2 O)
HELIX 1 1 MET A 172 GLY A 192 1 21
HELIX 2 2 SER A 202 HIS A 224 1 23
HELIX 3 3 HIS A 224 ASP A 236 1 13
HELIX 4 4 ASN A 239 SER A 255 1 17
HELIX 5 5 GLY A 262 ARG A 263 5 2
HELIX 6 6 VAL A 265 VAL A 265 5 1
HELIX 7 7 THR A 266 ILE A 281 1 16
HELIX 8 8 GLN A 283 SER A 285 5 3
HELIX 9 9 CYS A 286 GLN A 309 1 24
HELIX 10 10 ARG A 310 HIS A 320 1 11
HELIX 11 11 ASP B 173 GLY B 192 1 20
HELIX 12 12 SER B 202 HIS B 224 1 23
HELIX 13 13 HIS B 224 ASP B 236 1 13
HELIX 14 14 ASN B 239 SER B 245 1 7
HELIX 15 15 SER B 245 SER B 255 1 11
HELIX 16 16 ASN B 260 ILE B 281 1 22
HELIX 17 17 GLN B 283 SER B 285 5 3
HELIX 18 18 CYS B 286 GLN B 309 1 24
HELIX 19 19 ARG B 310 HIS B 320 1 11
HELIX 20 20 ASP C 173 GLY C 192 1 20
HELIX 21 21 SER C 202 HIS C 224 1 23
HELIX 22 22 HIS C 224 ASP C 236 1 13
HELIX 23 23 ASN C 239 SER C 255 1 17
HELIX 24 24 ASN C 260 ILE C 281 1 22
HELIX 25 25 GLN C 283 SER C 285 5 3
HELIX 26 26 CYS C 286 GLN C 309 1 24
HELIX 27 27 ARG C 310 HIS C 320 1 11
HELIX 28 28 ASP D 173 GLY D 192 1 20
HELIX 29 29 SER D 202 HIS D 224 1 23
HELIX 30 30 HIS D 224 ASP D 236 1 13
HELIX 31 31 ASN D 239 SER D 255 1 17
HELIX 32 32 ASN D 260 ILE D 281 1 22
HELIX 33 33 GLN D 283 SER D 285 5 3
HELIX 34 34 CYS D 286 GLN D 309 1 24
HELIX 35 35 ARG D 310 PHE D 319 1 10
HELIX 36 36 ASP E 173 GLY E 192 1 20
HELIX 37 37 SER E 202 HIS E 224 1 23
HELIX 38 38 HIS E 224 ASP E 236 1 13
HELIX 39 39 ASN E 239 SER E 255 1 17
HELIX 40 40 ASN E 260 ILE E 281 1 22
HELIX 41 41 GLN E 283 SER E 285 5 3
HELIX 42 42 CYS E 286 GLN E 309 1 24
HELIX 43 43 ARG E 310 PHE E 319 1 10
HELIX 44 44 ASP F 173 GLY F 192 1 20
HELIX 45 45 SER F 202 HIS F 224 1 23
HELIX 46 46 HIS F 224 ASP F 236 1 13
HELIX 47 47 ASN F 239 SER F 255 1 17
HELIX 48 48 ASN F 260 ILE F 281 1 22
HELIX 49 49 GLN F 283 SER F 285 5 3
HELIX 50 50 CYS F 286 GLN F 309 1 24
HELIX 51 51 ARG F 310 PHE F 319 1 10
SITE 1 AC1 14 PHE A 228 MET A 231 LEU A 235 MET A 250
SITE 2 AC1 14 VAL A 253 ARG A 263 THR A 266 LEU A 267
SITE 3 AC1 14 PHE A 270 ALA F 227 GLY F 230 MET F 231
SITE 4 AC1 14 LYS F 234 2UU F 401
SITE 1 AC2 13 PHE B 228 MET B 231 LEU B 235 ARG B 263
SITE 2 AC2 13 THR B 266 LEU B 267 PHE B 270 GLY B 271
SITE 3 AC2 13 ALA E 227 GLY E 230 LYS E 234 2UU E 401
SITE 4 AC2 13 HOH E 527
SITE 1 AC3 15 PHE C 228 MET C 231 LEU C 235 VAL C 253
SITE 2 AC3 15 PHE C 254 ARG C 263 THR C 266 LEU C 267
SITE 3 AC3 15 PHE C 270 LEU C 290 THR D 226 ALA D 227
SITE 4 AC3 15 GLY D 230 MET D 231 LYS D 234
SITE 1 AC4 14 THR C 226 ALA C 227 LYS C 234 PHE D 228
SITE 2 AC4 14 MET D 231 LEU D 235 MET D 250 VAL D 253
SITE 3 AC4 14 PHE D 254 ARG D 263 THR D 266 LEU D 267
SITE 4 AC4 14 PHE D 270 LEU D 290
SITE 1 AC5 16 THR B 226 ALA B 227 MET B 231 2UU B 401
SITE 2 AC5 16 PHE E 228 MET E 231 LYS E 234 LEU E 235
SITE 3 AC5 16 MET E 250 VAL E 253 PHE E 254 ARG E 263
SITE 4 AC5 16 THR E 266 LEU E 267 PHE E 270 LEU E 290
SITE 1 AC6 14 THR A 226 ALA A 227 MET A 231 2UU A 401
SITE 2 AC6 14 HOH A 517 MET F 231 LEU F 235 MET F 250
SITE 3 AC6 14 VAL F 253 PHE F 254 ARG F 263 THR F 266
SITE 4 AC6 14 LEU F 267 PHE F 270
CRYST1 71.112 109.750 76.544 90.00 93.31 90.00 P 1 21 1 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014062 0.000000 0.000813 0.00000
SCALE2 0.000000 0.009112 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013086 0.00000